{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:01:46Z","timestamp":1793232106992,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.prp.2011.03.002","type":"journal-article","created":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T15:36:28Z","timestamp":1304264188000},"page":"337-342","source":"Crossref","is-referenced-by-count":158,"title":["Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: Molecular bases for EGFR-targeted therapy"],"prefix":"10.1016","volume":"207","author":[{"given":"Pablo","family":"Uribe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prp.2011.03.002_bib0005","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1524-4725.2002.01169.x","article-title":"Prognostic factors for metastasis in squamous cell carcinoma of the skin","volume":"28","author":"Cherpelis","year":"2002","journal-title":"Dermatol. Surg."},{"issue":"1","key":"10.1016\/j.prp.2011.03.002_bib0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000246783","article-title":"Metastases from squamous cell carcinoma of the skin in southern Australia","volume":"189","author":"Czarnecki","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.prp.2011.03.002_bib0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1126\/science.959840","article-title":"The clonal evolution of tumor cell populations","volume":"194","author":"Nowell","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.prp.2011.03.002_bib0020","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","author":"Fearon","year":"1990","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.prp.2011.03.002_bib0025","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJMra021902","article-title":"Rules for making human tumor cells","volume":"347","author":"Hahn","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2011.03.002_bib0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","author":"Hanahan","year":"2000","journal-title":"Cell"},{"issue":"1 Pt. 2","key":"10.1016\/j.prp.2011.03.002_bib0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1067\/mjd.2000.103340","article-title":"The scientific basis of skin cancer","volume":"42","author":"Leffell","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"issue":"22","key":"10.1016\/j.prp.2011.03.002_bib0040","doi-asserted-by":"crossref","first-page":"10124","DOI":"10.1073\/pnas.88.22.10124","article-title":"A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma","volume":"88","author":"Brash","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6508","key":"10.1016\/j.prp.2011.03.002_bib0045","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/372773a0","article-title":"Sunburn and p53 in the onset of skin cancer","volume":"372","author":"Ziegler","year":"1994","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.prp.2011.03.002_bib0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1083\/jcb.200205017","article-title":"Gab1 and SHP-2 promote Ras\/MAPK regulation of epidermal growth and differentiation","volume":"159","author":"Cai","year":"2002","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.prp.2011.03.002_bib0055","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/sj.onc.1205287","article-title":"Epidermal Ras blockade demonstrates spatially localized Ras promotion of proliferation and inhibition of differentiation","volume":"21","author":"Dajee","year":"2002","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.prp.2011.03.002_bib0060","first-page":"319","article-title":"Inducible activation of Ras and Raf in adult epidermis","volume":"63","author":"Tarutani","year":"2003","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2011.03.002_bib0065","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mc.2940040306","article-title":"Ras gene mutation and amplification in human nonmelanoma skin cancers","volume":"4","author":"Pierceall","year":"1991","journal-title":"Mol. Carcinog."},{"issue":"6923","key":"10.1016\/j.prp.2011.03.002_bib0070","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nature01283","article-title":"NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia","volume":"421","author":"Dajee","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.prp.2011.03.002_bib0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1023\/A:1006491619920","article-title":"Ras activation in human breast cancer","volume":"62","author":"von Lintig","year":"2000","journal-title":"Breast Cancer Res. Treat."},{"issue":"4","key":"10.1016\/j.prp.2011.03.002_bib0080","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1046\/j.1523-1747.2001.01301.x","article-title":"PTCH mutations in squamous cell carcinoma of the skin","volume":"116","author":"Ping","year":"2001","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.prp.2011.03.002_bib0085","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/sj.jid.5700209","article-title":"Allelic loss at Drosophila patched gene is highly prevalent in Basal and squamous cell carcinomas of the skin","volume":"126","author":"Danaee","year":"2006","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.prp.2011.03.002_bib0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/1523-1747.ep12664612","article-title":"Microsatellite instability in human non-melanoma and melanoma skin cancer","volume":"104","author":"Quinn","year":"1995","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.prp.2011.03.002_bib0095","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/gcc.20183","article-title":"Cytogenetic alterations in nonmelanoma skin cancer: a review","volume":"43","author":"Ashton","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"10.1016\/j.prp.2011.03.002_bib0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.prp.2011.03.002_bib0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0092-8674(84)90296-4","article-title":"Growth factors: mechanism of action and relation to oncogenes","volume":"37","author":"Heldin","year":"1984","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.prp.2011.03.002_bib0110","first-page":"505","article-title":"The EGF receptor \u2013 an essential regulator of multiple epidermal functions","volume":"10","author":"Jost","year":"2000","journal-title":"Eur. J. Dermatol."},{"issue":"5967","key":"10.1016\/j.prp.2011.03.002_bib0115","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/309418a0","article-title":"Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells","volume":"309","author":"Ullrich","year":"1984","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.prp.2011.03.002_bib0120","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1158\/0008-5472.CAN-04-0214","article-title":"Complex regulation of signal transducers and activators of transcription 3 activation in normal and malignant keratinocytes","volume":"64","author":"Quadros","year":"2004","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2011.03.002_bib0125","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0012-1606(65)90005-9","article-title":"The stimulation of epidermal proliferation by a specific protein (EGF)","volume":"12","author":"Cohen","year":"1965","journal-title":"Dev. Biol."},{"issue":"Pt 2","key":"10.1016\/j.prp.2011.03.002_bib0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1242\/jcs.110.2.113","article-title":"EGF-R dependent regulation of keratinocyte survival","volume":"110","author":"Rodeck","year":"1997","journal-title":"J. Cell Sci."},{"issue":"13","key":"10.1016\/j.prp.2011.03.002_bib0135","first-page":"3759","article-title":"Alterations in gene expression and activity during squamous cell carcinoma development","volume":"62","author":"Serewko","year":"2002","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.prp.2011.03.002_bib0140","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1084\/jem.167.2.670","article-title":"Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes","volume":"167","author":"Gottlieb","year":"1988","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.prp.2011.03.002_bib0145","first-page":"1071","article-title":"Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas","volume":"4","author":"Dominey","year":"1993","journal-title":"Cell Growth Differ."},{"issue":"13","key":"10.1016\/j.prp.2011.03.002_bib0150","first-page":"3328","article-title":"The epidermal growth factor receptor is required to maintain the proliferative population in the basal compartment of epidermal tumors","volume":"60","author":"Hansen","year":"2000","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.prp.2011.03.002_bib0155","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(00)00026-X","article-title":"The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development","volume":"102","author":"Sibilia","year":"2000","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.prp.2011.03.002_bib0160","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ijc.2910520605","article-title":"EGF receptor expression in primary laryngeal cancer: correlation with clinico-pathological features and prognostic significance","volume":"52","author":"Maurizi","year":"1992","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2011.03.002_bib0165","first-page":"707","article-title":"Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors","volume":"47","author":"Derynck","year":"1987","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2011.03.002_bib0170","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/(SICI)1097-0142(19960915)78:6<1284::AID-CNCR17>3.0.CO;2-X","article-title":"Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck","volume":"78","author":"Rubin Grandis","year":"1996","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.prp.2011.03.002_bib0175","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/bjc.1996.525","article-title":"Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma","volume":"74","author":"Maurizi","year":"1996","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2011.03.002_bib0180","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/1097-0142(19910701)68:1<142::AID-CNCR2820680126>3.0.CO;2-X","article-title":"Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer","volume":"68","author":"Mukaida","year":"1991","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.prp.2011.03.002_bib0185","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/1097-0142(19890601)63:11<2169::AID-CNCR2820631117>3.0.CO;2-W","article-title":"Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomas","volume":"63","author":"Ozawa","year":"1989","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.prp.2011.03.002_bib0190","first-page":"111","article-title":"Prognostic significance of epidermal growth factor receptor in surgically treated squamous cell lung cancer patients","volume":"42","author":"Niemiec","year":"2004","journal-title":"Folia Histochem. Cytobiol."},{"issue":"24","key":"10.1016\/j.prp.2011.03.002_bib0195","first-page":"7350","article-title":"Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma","volume":"62","author":"Ang","year":"2002","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2011.03.002_bib0200","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000051637","article-title":"Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamous-cell carcinoma of the skin","volume":"202","author":"Shimizu","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.prp.2011.03.002_bib0205","first-page":"1205","article-title":"Immunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin","volume":"25","author":"Maubec","year":"2005","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.prp.2011.03.002_bib0210","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-0560.1992.tb01561.x","article-title":"Abnormal expression of epidermal growth factor receptor in cutaneous epithelial tumours","volume":"19","author":"Groves","year":"1992","journal-title":"J. Cutan. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2011.03.002_bib0215","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2133.2006.07603.x","article-title":"Characterization of the expression and activation of the epidermal growth factor receptor in squamous cell carcinoma of the skin","volume":"156","author":"Fogarty","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.prp.2011.03.002_bib0220","unstructured":"M. Naranjo, An\u00e1lisis comparativo de la expresi\u00f3n inmunohistoqu\u00edmica del receptor de factor de crecimiento epid\u00e9rmico en carcinoma espinocelular y queratoacantoma de la piel, in Tesis de post\u00edtulo en Dermatolog\u00eda, UDA Dermatolog\u00eda, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, 2007."},{"issue":"16","key":"10.1016\/j.prp.2011.03.002_bib0225","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1200\/JCO.2006.06.6605","article-title":"Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer","volume":"25","author":"Temam","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"19","key":"10.1016\/j.prp.2011.03.002_bib0230","doi-asserted-by":"crossref","first-page":"9304","DOI":"10.1158\/0008-5472.CAN-07-0798","article-title":"Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib","volume":"67","author":"Timpson","year":"2007","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.prp.2011.03.002_bib0235","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1158\/0008-5472.CAN-04-2204","article-title":"Chemoprevention of UV light-induced skin tumorigenesis by inhibition of the epidermal growth factor receptor","volume":"65","author":"El-Abaseri","year":"2005","journal-title":"Cancer Res."},{"issue":"7015","key":"10.1016\/j.prp.2011.03.002_bib0240","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nature03095","article-title":"Targeted cancer therapy","volume":"432","author":"Sawyers","year":"2004","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.prp.2011.03.002_bib0245","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.prp.2011.03.002_bib0250","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0959-8049(01)00231-3","article-title":"EGFR and cancer prognosis","volume":"37","author":"Nicholson","year":"2001","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2011.03.002_bib0255","first-page":"893","article-title":"Characterisation and predictive value of epidermal growth factor receptor status using quantitative real-time PCR combined with immunohistochemistry on non-small cell lung cancer specimens","volume":"23","author":"Hilbe","year":"2003","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2011.03.002_bib0260","first-page":"461","article-title":"Ultraviolet irradiation activates PI 3-kinase\/AKT survival pathway via EGF receptors in human skin in vivo","volume":"18","author":"Wan","year":"2001","journal-title":"Int. J. Oncol."},{"issue":"5578","key":"10.1016\/j.prp.2011.03.002_bib0265","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1126\/science.1073096","article-title":"Cancer. Addiction to oncogenes \u2013 the Achilles heal of cancer","volume":"297","author":"Weinstein","year":"2002","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.prp.2011.03.002_bib0270","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.1158\/1078-0432.CCR-06-0646","article-title":"Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs","volume":"12","author":"Ono","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2011.03.002_bib0275","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/jnci\/dji112","article-title":"Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer","author":"Cappuzzo","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.prp.2011.03.002_bib0280","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ijc.21496","article-title":"Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers","volume":"118","author":"Shigematsu","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"17","key":"10.1016\/j.prp.2011.03.002_bib0285","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1158\/0008-5472.CAN-05-1705","article-title":"EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients","volume":"65","author":"Tang","year":"2005","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.prp.2011.03.002_bib0290","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-04-1894","article-title":"Somatic mutations of epidermal growth factor receptor in colorectal carcinoma","volume":"11","author":"Nagahara","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2011.03.002_bib0295","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejca.2005.08.034","article-title":"Low incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinoma","volume":"42","author":"Loeffler-Ragg","year":"2006","journal-title":"Eur. J. Cancer"},{"issue":"8","key":"10.1016\/j.prp.2011.03.002_bib0300","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1158\/1078-0432.CCR-04-2029","article-title":"Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck","volume":"11","author":"Lee","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"24","key":"10.1016\/j.prp.2011.03.002_bib0305","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1158\/1078-0432.CCR-06-0658","article-title":"Update on epidermal growth factor receptor mutations in non-small cell lung cancer","volume":"12","author":"Riely","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.prp.2011.03.002_bib0310","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1056\/NEJMoa050736","article-title":"Erlotinib in lung cancer \u2013 molecular and clinical predictors of outcome","volume":"353","author":"Tsao","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.prp.2011.03.002_bib0315","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1158\/1078-0432.CCR-04-2618","article-title":"Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas","volume":"11","author":"Taron","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"5676","key":"10.1016\/j.prp.2011.03.002_bib0320","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.prp.2011.03.002_bib0325","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.prp.2011.03.002_bib0330","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.molmed.2004.08.008","article-title":"Mutations and addiction to EGFR: the Achilles heal\u2019 of lung cancers?","volume":"10","author":"Gazdar","year":"2004","journal-title":"Trends Mol. Med."},{"issue":"5","key":"10.1016\/j.prp.2011.03.002_bib0335","first-page":"1383","article-title":"Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas","volume":"60","author":"Frederick","year":"2000","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.prp.2011.03.002_bib0340","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1158\/1078-0432.CCR-04-1737","article-title":"Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients","volume":"11","author":"Heimberger","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"16","key":"10.1016\/j.prp.2011.03.002_bib0345","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1073\/pnas.91.16.7727","article-title":"A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity","volume":"91","author":"Nishikawa","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"19","key":"10.1016\/j.prp.2011.03.002_bib0350","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1056\/NEJMoa051918","article-title":"Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors","volume":"353","author":"Mellinghoff","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.prp.2011.03.002_bib0355","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/modpathol.3800552","article-title":"Detection of EGFR- and HER2-activating mutations in squamous cell carcinoma involving the head and neck","volume":"19","author":"Willmore-Payne","year":"2006","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2011.03.002_bib0360","doi-asserted-by":"crossref","unstructured":"K. Ridd, B.C. Bastian, Somatic mutation of epidermal growth factor receptor in a small subset of cutaneous squamous cell carcinoma, J. Invest. Dermatol. 130 (3) (2010) 901\u2013903.","DOI":"10.1038\/jid.2009.312"},{"issue":"3","key":"10.1016\/j.prp.2011.03.002_bib0365","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.humpath.2007.07.004","article-title":"Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma","volume":"39","author":"Ch\u2019ng","year":"2008","journal-title":"Hum. Pathol."},{"issue":"25","key":"10.1016\/j.prp.2011.03.002_bib0370","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1200\/JCO.2006.07.2587","article-title":"Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas","volume":"24","author":"Chung","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2011.03.002_bib0375","doi-asserted-by":"crossref","unstructured":"A. Toll, et al., Epidermal growth factor receptor gene numerical aberrations are frequent events in actinic keratoses and invasive cutaneous squamous cell carcinomas, Exp. Dermatol. 19 (2) (2010) 151\u2013153.","DOI":"10.1111\/j.1600-0625.2009.01028.x"},{"issue":"17","key":"10.1016\/j.prp.2011.03.002_bib0380","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-06-0913","article-title":"Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting","volume":"12","author":"Sok","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.prp.2011.03.002_bib0385","first-page":"345","article-title":"Suppression of epidermal growth factor receptor, mitogen-activated protein kinase, and Pak1 pathways and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa)","volume":"2","author":"Barnes","year":"2003","journal-title":"Mol. Cancer Ther."},{"issue":"10","key":"10.1016\/j.prp.2011.03.002_bib0390","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1200\/JCO.2003.10.051","article-title":"Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck","volume":"21","author":"Cohen","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"6B","key":"10.1016\/j.prp.2011.03.002_bib0395","first-page":"3985","article-title":"Reduction of cisplatin dosage by ZD 1839","volume":"25","author":"Hambek","year":"2005","journal-title":"Anticancer Res."},{"issue":"6","key":"10.1016\/j.prp.2011.03.002_bib0400","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"18S","key":"10.1016\/j.prp.2011.03.002_bib0405","doi-asserted-by":"crossref","first-page":"p5531","DOI":"10.1200\/jco.2006.24.18_suppl.5531","article-title":"Phase II study of gefitinib in patients with metastatic\/recurrent squamous cell carcinoma of the skin. 2006 ASCO Annual Meeting Proceedings","volume":"24","author":"Glisson","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.prp.2011.03.002_bib0410","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archderm.143.7.889","article-title":"Treatment of recurrent squamous cell carcinoma of the skin with cetuximab","volume":"143","author":"Bauman","year":"2007","journal-title":"Arch. Dermatol."},{"issue":"7","key":"10.1016\/j.prp.2011.03.002_bib0415","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/CAD.0b013e32809ef9e0","article-title":"Cutaneous squamous cell carcinoma responding serially to single-agent cetuximab","volume":"18","author":"Suen","year":"2007","journal-title":"Anticancer Drugs"},{"issue":"3","key":"10.1016\/j.prp.2011.03.002_bib0420","first-page":"581","article-title":"Erlotinib-responsive actinic keratoses","volume":"18","author":"Hermanns","year":"2007","journal-title":"Oncol. Rep."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033811000689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033811000689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T07:14:40Z","timestamp":1637565280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033811000689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":84,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0344033811000689"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2011.03.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718484010.793496928","asserted-by":"object"}]},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}